Skip to content

APOTHEEK PENEL: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK PENEL

BE 0441.587.451
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 compared with 2023filed annual accounts (NBB)
Net result for the year
€5,542
2023 · €4,076+€1,466
Equity
€12,185
2023 · €6,643+€5,542
Cash
€10,080
2023 · €7,972+€2,108
Balance sheet total
€277,104
2023 · €264,264+€12,839

Largest movements

2023 to 2024
Assets
  • Stocks and contracts +€14,596

    up €14,596 (+17.1%), from €85,359 to €99,955

  • Receivables within one year -€9,602

    down €9,602 (-6.1%), from €157,404 to €147,802

    of which Other amounts receivable: -€5,263

  • Deferred charges and accrued income +€6,451

    up €6,451 (+60.2%), from €10,718 to €17,169

Equity and liabilities
  • Trade debts +€10,775

    up €10,775 (+11.6%), from €93,053 to €103,828

  • Other debts -€5,896

    down €5,896 (-4.5%), from €130,121 to €124,225

  • Profit (loss) carried forward +€5,542

    up €5,542 (+2.6%), from -€210,930 to -€205,388

  • Debts after one year -€3,827

    down €3,827 (-25.9%), from €14,781 to €10,953

  • Tax, wage and social debts +€3,354

    up €3,354 (+30.5%), from €10,988 to €14,342

    of which Remuneration and social security: +€4,523

Income statement
  • Gross operating margin +€4,472

    up €4,472 (+7.7%), from €58,333 to €62,805

  • Staff costs +€2,715

    up €2,715 (+6.4%), from €42,332 to €45,047

  • Financial charges +€1,419

    up €1,419 (+8.9%), from €15,962 to €17,381

  • Financial income +€1,178

    up €1,178 (+24.4%), from €4,836 to €6,015

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 €4,076
Gross operating margin +€4,472
Staff costs -€2,715
Depreciation -€0
Other operating charges -€50
Financial income +€1,178
Financial charges -€1,419
Result 2024 €5,542
raises the resultlowers the result

Derived cash bridge

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€5,618
Investment €0
Financing -€3,510
Cash 2023 €7,972
Net result for the year +€5,542
Depreciation +€714
Stocks and contracts -€14,596
Receivables within one year +€9,602
Deferred charges and accrued income -€6,451
Trade debts +€10,775
Tax, wage and social debts +€3,354
Other debts -€5,896
Accrued charges and deferred income +€2,574
Debts after one year -€3,827
Current portion of long-term debt +€318
Cash 2024 €10,080
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2023 2024 Change %
Total assets 20/58 €264,264 €277,104 +€12,839 +4.9%
Fixed assets 21/28 €2,811 €2,097 -€714 -25.4%
Tangible fixed assets 22/27 €2,687 €1,973 -€714 -26.6%
Plant, machinery and equipment 23 €2,687 €1,973 -€714 -26.6%
Financial fixed assets 28 €124 €124 = 0.0%
Current assets 29/58 €261,454 €275,007 +€13,553 +5.2%
Stocks and contracts in progress 3 €85,359 €99,955 +€14,596 +17.1%
Stocks 30/36 €85,359 €99,955 +€14,596 +17.1%
Amounts receivable within one year 40/41 €157,404 €147,802 -€9,602 -6.1%
Trade receivables 40 €76,604 €72,265 -€4,339 -5.7%
Other amounts receivable 41 €80,800 €75,537 -€5,263 -6.5%
Cash at bank and in hand 54/58 €7,972 €10,080 +€2,108 +26.4%
Deferred charges and accrued income 490/1 €10,718 €17,169 +€6,451 +60.2%
Total equity and liabilities 10/49 €264,264 €277,104 +€12,839 +4.9%
Equity 10/15 €6,643 €12,185 +€5,542 +83.4%
Contributions 10/11 €61,973 €61,973 = 0.0%
Capital 10 €61,973 €61,973 = 0.0%
Issued capital 100 €61,973 €61,973 = 0.0%
Reserves 13 €155,600 €155,600 = 0.0%
Non-distributable reserves 130/1 €6,197 €6,197 = 0.0%
Legal reserve 130 €6,197 €6,197 = 0.0%
Distributable reserves 133 €149,402 €149,402 = 0.0%
Profit (loss) carried forward 14 -€210,930 -€205,388 +€5,542 +2.6%
Amounts payable 17/49 €257,621 €264,918 +€7,297 +2.8%
Amounts payable after more than one year 17 €14,781 €10,953 -€3,827 -25.9%
Financial debts 170/4 €14,781 €10,953 -€3,827 -25.9%
Amounts payable within one year 42/48 €237,672 €246,222 +€8,551 +3.6%
Current portion of amounts payable after more than one year 42 €3,510 €3,827 +€318 +9.1%
Trade debts 44 €93,053 €103,828 +€10,775 +11.6%
Suppliers 440/4 €93,053 €103,828 +€10,775 +11.6%
Taxes, remuneration and social security 45 €10,988 €14,342 +€3,354 +30.5%
Taxes 450/3 €1,538 €369 -€1,169 -76.0%
Remuneration and social security 454/9 €9,450 €13,973 +€4,523 +47.9%
Other amounts payable 47/48 €130,121 €124,225 -€5,896 -4.5%
Accrued charges and deferred income 492/3 €5,169 €7,743 +€2,574 +49.8%
Remuneration, social security and pensions 62 €42,332 €45,047 +€2,715 +6.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €714 €714 +€0 0.0%
Other operating charges 640/8 €85 €135 +€50 +59.3%
Gross operating margin 9900 €58,333 €62,805 +€4,472 +7.7%
Operating profit (loss) 9901 €15,202 €16,908 +€1,706 +11.2%
Financial income 75/76B €4,836 €6,015 +€1,178 +24.4%
Recurring financial income 75 €4,836 €6,015 +€1,178 +24.4%
Financial charges 65/66B €15,962 €17,381 +€1,419 +8.9%
Recurring financial charges 65 €15,962 €17,381 +€1,419 +8.9%
Profit (loss) for the period before taxes 9903 €4,076 €5,542 +€1,466 +36.0%
Profit (loss) for the period 9904 €4,076 €5,542 +€1,466 +36.0%
Profit (loss) for the period to be appropriated 9905 €4,076 €5,542 +€1,466 +36.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.